Joris Wilms - Net Worth and Insider Trading

Joris Wilms Net Worth

The estimated net worth of Joris Wilms is at least $363,528 dollars as of 2024-11-29. Joris Wilms is the SVP & CHIEF OPERATING OFFICER of Y-mAbs Therapeutics Inc and owns about 30,600 shares of Y-mAbs Therapeutics Inc (YMAB) stock worth over $363,528. Details can be seen in Joris Wilms's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joris Wilms has not made any transactions after 2024-08-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Joris Wilms

To

Joris Wilms Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joris Wilms owns 1 companies in total, including Y-mAbs Therapeutics Inc (YMAB) .

Click here to see the complete history of Joris Wilms’s form 4 insider trades.

Insider Ownership Summary of Joris Wilms

Ticker Comapny Transaction Date Type of Owner
YMAB Y-mAbs Therapeutics Inc 2024-08-26 Sr. VP and COO

Joris Wilms Latest Holdings Summary

Joris Wilms currently owns a total of 1 stock. Joris Wilms owns 30,600 shares of Y-mAbs Therapeutics Inc (YMAB) as of August 26, 2024, with a value of $363,528.

Latest Holdings of Joris Wilms

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
YMAB Y-mAbs Therapeutics Inc 2024-08-26 30,600 11.88 363,528

Holding Weightings of Joris Wilms


Joris Wilms Form 4 Trading Tracker

According to the SEC Form 4 filings, Joris Wilms has made a total of 1 transactions in Y-mAbs Therapeutics Inc (YMAB) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Y-mAbs Therapeutics Inc is the sale of 5,000 shares on August 26, 2024, which brought Joris Wilms around $73,450.

Insider Trading History of Joris Wilms

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joris Wilms Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Joris Wilms Ownership Network

Ownership Network List of Joris Wilms

No Data

Ownership Network Relation of Joris Wilms

Insider Network Chart

Joris Wilms Owned Company Details

What does Y-mAbs Therapeutics Inc do?

Who are the key executives at Y-mAbs Therapeutics Inc?

Joris Wilms is the Sr. VP and COO of Y-mAbs Therapeutics Inc. Other key executives at Y-mAbs Therapeutics Inc include director & President and Chairman Thomas Gad , Sr. VP and Head of Tech Op Torben Lund-hansen , and director & EVP & CFO & Secy & Treas. Bo Kruse .

Y-mAbs Therapeutics Inc (YMAB) Insider Trades Summary

Over the past 18 months, Joris Wilms made 1 insider transaction in Y-mAbs Therapeutics Inc (YMAB) with a net sale of 5,000. Other recent insider transactions involving Y-mAbs Therapeutics Inc (YMAB) include a net sale of 501,251 shares made by Thomas Gad , a net purchase of 279,028 shares made by Johan Wedell-wedellsborg , and a net purchase of 279,028 shares made by Biotech Aps Wg .

In summary, during the past 3 months, insiders sold 95,000 shares of Y-mAbs Therapeutics Inc (YMAB) in total and bought 0 shares, with a net sale of 95,000 shares. During the past 18 months, 620,366 shares of Y-mAbs Therapeutics Inc (YMAB) were sold and 558,056 shares were bought by its insiders, resulting in a net sale of 62,310 shares.

Y-mAbs Therapeutics Inc (YMAB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Y-mAbs Therapeutics Inc Insider Transactions

No Available Data

Joris Wilms Mailing Address

Above is the net worth, insider trading, and ownership report for Joris Wilms. You might contact Joris Wilms via mailing address: C/o Y-mabs Therapeutics, Inc., 230 Park Avenue, 33rd Floor, New York Ny 10169.

Discussions on Joris Wilms

No discussions yet.